BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 31696268)

  • 1. LI-RADS and transplantation: challenges and controversies.
    Cunha GM; Tamayo-Murillo DE; Fowler KJ
    Abdom Radiol (NY); 2021 Jan; 46(1):29-42. PubMed ID: 31696268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Organ Procurement and Transplantation Network hepatocellular carcinoma classification: Alignment with Liver Imaging Reporting and Data System, current gaps, and future direction.
    Kierans AS; Chernyak V; Mendiratta-Lala M; Sirlin CB; Hecht EM; Fowler KJ
    Liver Transpl; 2023 Feb; 29(2):206-216. PubMed ID: 36097856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
    Kierans AS; Song C; Gavlin A; Roudenko A; Lu L; Askin G; Hecht EM
    AJR Am J Roentgenol; 2020 Nov; 215(5):1085-1092. PubMed ID: 32877248
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance of LI-RADS Version 2018 on CT for Determining Eligibility for Liver Transplant According to Milan Criteria in Patients at High Risk for Hepatocellular Carcinoma.
    Bae JS; Lee DH; Lee SM; Suh KS; Lee KW; Yi NJ; Lee KB; Kim H; Han JK
    AJR Am J Roentgenol; 2022 Jul; 219(1):86-96. PubMed ID: 35138137
    [No Abstract]   [Full Text] [Related]  

  • 5. Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications.
    Bashir MR; Huang R; Mayes N; Marin D; Berg CL; Nelson RC; Jaffe TA
    J Magn Reson Imaging; 2015 Aug; 42(2):305-14. PubMed ID: 25371354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver Imaging Reporting and Data System Version 2018: Impact on Categorization and Hepatocellular Carcinoma Staging.
    Chernyak V; Flusberg M; Berman J; Fruitman KC; Kobi M; Fowler KJ; Sirlin CB
    Liver Transpl; 2019 Oct; 25(10):1488-1502. PubMed ID: 31344753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma.
    Kierans AS; Makkar J; Guniganti P; Cornman-Homonoff J; Lee MJ; Pittman M; Askin G; Hecht EM
    J Magn Reson Imaging; 2019 Jun; 49(7):e205-e215. PubMed ID: 30257054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma.
    Fowler KJ; Karimova EJ; Arauz AR; Saad NE; Brunt EM; Chapman WC; Heiken JP
    Transplantation; 2013 Jun; 95(12):1506-11. PubMed ID: 23778569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
    Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
    World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
    Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. User and system pitfalls in liver imaging with LI-RADS.
    Elsayes KM; Fowler KJ; Chernyak V; Elmohr MM; Kielar AZ; Hecht E; Bashir MR; Furlan A; Sirlin CB
    J Magn Reson Imaging; 2019 Dec; 50(6):1673-1686. PubMed ID: 31215119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI.
    Elsayes KM; Kielar AZ; Elmohr MM; Chernyak V; Masch WR; Furlan A; Marks RM; Cruite I; Fowler KJ; Tang A; Bashir MR; Hecht EM; Kamaya A; Jambhekar K; Kamath A; Arora S; Bijan B; Ash R; Kassam Z; Chaudhry H; McGahan JP; Yacoub JH; McInnes M; Fung AW; Shanbhogue K; Lee J; Deshmukh S; Horvat N; Mitchell DG; Do RKG; Surabhi VR; Szklaruk J; Sirlin CB
    Abdom Radiol (NY); 2018 Oct; 43(10):2625-2642. PubMed ID: 30155697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018.
    Ludwig DR; Fraum TJ; Cannella R; Ballard DH; Tsai R; Naeem M; LeBlanc M; Salter A; Tsung A; Shetty AS; Borhani AA; Furlan A; Fowler KJ
    Abdom Radiol (NY); 2019 Jun; 44(6):2116-2132. PubMed ID: 30798397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive diagnostic criteria of hepatocellular carcinoma: Comparison of diagnostic accuracy of updated LI-RADS with clinical practice guidelines of OPTN-UNOS, AASLD, NCCN, EASL-EORTC, and KLSCG-NCC.
    Erkan B; Meier J; Clark TJ; Kaplan J; Lambert JR; Chang S
    PLoS One; 2019; 14(12):e0226291. PubMed ID: 31821360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
    Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
    J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging.
    Davenport MS; Khalatbari S; Liu PS; Maturen KE; Kaza RK; Wasnik AP; Al-Hawary MM; Glazer DI; Stein EB; Patel J; Somashekar DK; Viglianti BL; Hussain HK
    Radiology; 2014 Jul; 272(1):132-42. PubMed ID: 24555636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B; Wildner D; Pfeifer L; Goertz RS; Hagel A; Neurath MF; Strobel D
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [No Abstract]   [Full Text] [Related]  

  • 19. LI-RADS and transplantation for hepatocellular carcinoma.
    Tang A; Fowler KJ; Chernyak V; Chapman WC; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):193-202. PubMed ID: 28612162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS.
    Liu W; Qin J; Guo R; Xie S; Jiang H; Wang X; Kang Z; Wang J; Shan H
    Acta Radiol; 2018 Feb; 59(2):140-146. PubMed ID: 28648125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.